Alex Therapeutics designs and creates CE-certified Digital Therapeutics (DTx) medical products that combine AI with CBT.
At Alex Therapeutics, we develop CE-certified Digital Therapeutics (DTx) products. We are a pioneer within our field, combining Cognitive Behavioural Therapy (CBT) and Acceptance and Commitment Therapy (ACT) with Artificial Intelligence to provide our patients with highly personalized and effective care. Our first product, Alex Smoke-Free, combines CBT with AI to help the user become smoke-free. 50,000 people on three continents currently use it, and 52% of those who go through the program successfully quit smoking, 7 times more than nicotine replacement medicine. The Alex Platform allows for the easy development of new products and we see incredible potential in future verticals such as obesity, depression, oncology, and more.
B2C, B2B
1 to 25
Funded
$628,422
Scaling Up
2018
Medical Devices
Healthcare
Digital Medicine That Treats Unhealthy Habits
Healthcare
Service
Yes
Active
Machine Learning
Machine Perception
Natural Language Processing
Software
N/A
Software Engineer
Stockholm, Stockholm
Product Designer
Stockholm, Stockholm
Business Intern
Stockholm, Stockholm
AI/ML Professionals
Want to work at Alex Therapeutics?
We can introduce you to the right person at Alex Therapeutics
3
1
$3.8M
Company was founded 2018 and it took almost 4 years (Apr 2022) to raise first external round
Investors
Interested in researching Alex Therapeutics?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Alex Therapeutics
Potential Customers
Interested in what they do or partnership?
Learn more about how they work